1.97
price down icon1.01%   -0.02
after-market Handel nachbörslich: 1.93 -0.04 -2.03%
loading

Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten

pulisher
Jun 18, 2025

Gene-Editing Stocks Gain on LLY-VERV Deal Announcement - TradingView

Jun 18, 2025
pulisher
Jun 16, 2025

SpringWorks Therapeutics (SWTX) Continues Strong Yearly Run, Showing Over 29% YTD Gain - Daily Chhattisgarh News

Jun 16, 2025
pulisher
Jun 15, 2025

Stellantis (NYSE:STLA) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Pharmaceutical Stocks Worth Watching – June 13th - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jun 13, 2025
pulisher
Jun 11, 2025

CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Gain Therapeutics to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph

Jun 10, 2025
pulisher
Jun 10, 2025

Gain Therapeutics Opens Access to Management: CEO Featured at Two Major Biotech Investor Conferences - Stock Titan

Jun 10, 2025
pulisher
Jun 08, 2025

Aquestive Therapeutics: Anaphylm Could Gain Significant Market Share (NASDAQ:AQST) - Seeking Alpha

Jun 08, 2025
pulisher
Jun 04, 2025

Telix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer Detection - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Raises Holdings in Banco Bradesco S.A. (NYSE:BBDO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Invests $208,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $226,000 Position in LightPath Technologies, Inc. (NASDAQ:LPTH) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Shares Purchased by Northern Trust Corp - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

i-80 Gold Corp. (NYSE:IAUX) Receives $3.50 Average PT from Brokerages - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Increases Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Purchases 10,466 Shares of United-Guardian, Inc. (NASDAQ:UG) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Grows Stock Holdings in Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
May 29, 2025

Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting - The Manila Times

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics, Inc. Announces Oral Presentation at GBA1 Meeting 2025 in Montreal - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics' Chief Medical Officer Set to Reveal Latest GBA1 Therapeutic Developments in Montreal - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Gain Therapeutics Files $100 Million Mixed Shelf - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offerin - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offering | GANX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings - Benzinga

May 28, 2025
pulisher
May 23, 2025

CytomX Therapeutics Inc’s (CTMX) 4.41% Gain Is A Reason To Reconsider. - Stocksregister

May 23, 2025
pulisher
May 22, 2025

HC Wainwright Brokers Increase Earnings Estimates for GANX - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 176,437 Shares of Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World

May 21, 2025
pulisher
May 21, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of “Buy” by Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Gain Therapeutics (GANX) Maintains 'Buy' Rating with $8 Price Ta - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Roth Capital Predicts Reduced Earnings for Gain Therapeutics - Defense World

May 19, 2025
pulisher
May 15, 2025

Gain Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 15, 2025
pulisher
May 14, 2025

Gain Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Gain (GANX) Advances Parkinson's Treatment in Phase 1b Trials | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics, Inc. Reports Q1 2025 Financial Results and Corporate Update, Highlights Progress in Parkinson’s Disease Drug Development - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics' Parkinson's Drug Shows Promise: Key Biomarker Data Coming Mid-2025 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Zevra Therapeutics Q1 Net Loss Narrows, Revenue Rises; Shares Gain After Hours - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Crude Oil Gains 3%; US Inflation Eases In April - Benzinga

May 13, 2025
pulisher
May 12, 2025

Gain Therapeutics (GANX) Showcases Promising Parkinson's Treatme - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics, Inc. Presents New Evidence for GT-02287 as Potential Disease-Modifying Therapy for Parkinson’s Disease at IAPRD 30th World Congress - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders - TradingView

May 12, 2025
pulisher
May 11, 2025

Gain Therapeutics (GANX) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Halozyme Therapeutics, Inc. (HALO): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Celldex Therapeutics, Inc. (CLDX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Protagonist Therapeutics, Inc. (PTGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Gaining Ground: Verve Therapeutics Inc (VERV) Closes Lower at 5.95, Down -11.33 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Closing Figures Unveiled: Indaptus Therapeutics Inc (INDP) Gain 7.96, Closes at 0.71 - DWinneX

May 09, 2025
pulisher
May 08, 2025

Market Insights: Trevi Therapeutics Inc (TRVI)’s Notable Gain of 1.22, Closing at 6.66 - DWinneX

May 08, 2025
pulisher
May 05, 2025

GANXGain Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

May 05, 2025
pulisher
May 05, 2025

Recursion Pharmaceuticals (NasdaqGS:RXRX) Reports Q1 Sales Increase and REC-4881 Trial Results - Yahoo Finance

May 05, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):